Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artis Biotech is a private company supplying pharmaceutical analytical standards, stable-isotope labeled internal standards, metabolites, degradation compounds, impurities, and inhibitor reference compounds used in bioanalysis, bioequivalence studies, and generic drug development. The company also offers custom synthesis and analytical services for pharmaceutical, biotechnology, clinical, and bio-analytical customers. Its business appears to be focused on research-enabling products and chemistry services rather than on developing therapeutic drug candidates of its own. Public website materials indicate operations in India and China and position the company under the "ARTIS STANDARDS" brand. Based on the available evidence, this is best characterized as a commercial life science supplier/CRO-style chemistry services company rather than a therapeutics biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artis Biopharma.